BioAmber Inc. Cashflow Statement

Ask AI

Overview Financial Statements SEC Filings Executives News Red Flags Capital Raising Ownership Insider Transactions Congressional Trades

Financial Statements

Income Statement Balance Sheet Cashflow Statement

Consolidated Statements of Cash Flows

In millions of USD, except per-share amounts

	FY2017 12 months to Dec 31, 2017	FY2016 12 months to Dec 31, 2016	FY2015 12 months to Dec 31, 2015	FY2014 12 months to Dec 31, 2014	FY2013 12 months to Dec 31, 2013
Cash flows from operating activities
Net loss
Adjustments to reconcile net loss to cash:
Stock-based compensation
Depreciation of property and equipment and amortization of intangible assets
Impairment loss and write-off of property and equipment and of intangible assets
Amortization of deferred financing costs and debt discounts
Disposal of fixed assets
Equity participation in losses of equity method investments
Other long-term liabilities
Gain on re-measurement of Bioamber S.A.S (Note 4)
Financial (income) charges, net (Note 10)
(Gain) loss on debt extinguishment (Note 11)
Gain on debt extinguishment (Note 8)
Grant income
Write-off of deferred financing costs
Changes in operating assets and liabilities
Change in accounts receivable
Change in restricted cash
Capital redistribution from (investment in) equity method investments (Note 3)
Net cash from acquisition of Bioamber S.A.S. (Note 4)
Net cash used in investing activities
Change in inventories
Change in prepaid expenses and deposits
Change in deferred revenues
Change in value added tax, income taxes and other receivables
Change in accounts payable to ARD
Change in accounts payable and accrued liabilities

Net cash used in operating activities

Net cash used in operating activities
Cash flows from investing activities
Acquisition of property and equipment
Acquisition of property and equipment and intangible assets, net of sales of assets
Capital investment in equity method and cost investments (Note 3)
Net cash used in investing activities

Cash flows from financing activities
Deferred financing costs
Issuance of long-term debt (Note 8)
Repayment of long-term debt (Note 8)
Government grants (Note 9)
Net proceeds from issuance of common shares
Proceeds from issuance of shares by a subsidiary (Note 12)
Net proceeds on issuance of units (Note 13)
Cancellation of shares
Net cash provided by financing activities

Foreign exchange impact on cash
(Decrease) increase in cash
Cash and cash equivalents, beginning of period
Cash and cash equivalents, end of period
Supplemental cash flow information:
Deferred financing costs related to the second public offering not yet paid
Non-cash transactions:
Deferred financing costs related to the public offering not yet paid
Construction in-progress costs and fixed assets not yet paid
Amortization of debt discounts capitalized to Fixed Assets
Interest paid

Comments